Importance of pharmacologic considerations in the development of targeted anticancer agents for children

aDivision of Oncology, Center of Childhood Cancer Research, Children's Hospital of Philadelphia

bUniversity of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA

Correspondence to Patrick J. Grohar, Childrens Hospital of Philadelphia, Philadelphia, PA USA. E-mail: [email protected]

留言 (0)

沒有登入
gif